CONTENTS:
• Do alcohol-dependent individuals with DRD2 A1 allele have an increased risk of relapse? A Pilot Study. Dahlgren A., Wargelius H.L., Berglund K.J., Fahlke C., Blennow K., Zetterberg H., et al., p. 509-513.
• Combined pre- and postnatal ethanol exposure in rats disturbs the myelination of optic axons. Pons-Vazquez S., Gallego-Pinazo R., Galbis-Estrada C., Zanon-Moreno V., Garcia-Medina J.J., Vila-Bou V., et al., p. 514-522.
• The acute effect of ethanol on adrenal cortex in female rats--possible role of nitric oxide. Dikic D., Budec M., Vranjes-Duric S., Koko V., Vignjevic S., Mitrovic O., p. 523-528.
• Interleukin-15 and other myokines in chronic alcoholics. Gonzalez-Reimers E., Fernandez-Rodriguez C.M., Santolaria-Fernandez F., Vega-Prieto M.J., Martin-Gonzalez C., Gomez-Rodriguez M.A., et al., p. 529-533.
• Evaluation of myocyte proliferation in alcoholic cardiomyopathy: telomerase enzyme activity (TERT) compared with Ki-67 expression. Lluis M., Fernandez-Sola J., Castellvi-Bel S., Sacanella E., Estruch R., Urbano-Marquez A., p. 534-541.
• Assessment of the mode of anger expression in alcohol dependent male inpatients. Demirbas H., Ilhan I.O., Dogan Y.B., p. 542-546.
• Alcohol attenuates activation in the bilateral anterior insula during an emotional processing task: a pilot study. Padula C.B., Simmons A.N., Matthews S.C., Robinson S.K., Tapert S.F., Schuckit M.A., et al., p. 547-552.
• Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo. Dahl H., Hammarberg A., Franck J., Helander A., p. 553-557.
• Nutritional evaluation of alcoholic inpatients admitted for alcohol detoxification. Teixeira J., Mota T., Fernandes J.C., p. 558-560.
• A randomized clinical trial of a therapeutic workplace for chronically unemployed, homeless, alcohol-dependent adults. Koffarnus M.N., Wong C.J., Diemer K., Needham M., Hampton J., Fingerhood M., et al., p. 561-569.
• Intervention against excessive alcohol consumption in primary health care: a survey of GPs' attitudes and practices in England 10 years on. Wilson G.B., Lock C.A., Heather N., Cassidy P., Christie M.M., Kaner E.F., p. 570-577.
• Pharmacological treatment of insomnia in alcohol recovery: a systematic review. Kolla B.P., Mansukhani M.P., Schneekloth T., p. 578-585.
• Is controlled drinking an acceptable goal in the treatment of alcohol dependence? A survey of French alcohol specialists. Luquiens A., Reynaud M., Aubin H.J., p. 586-591.
• Exploring treatment attendance and its relationship to outcome in a randomized controlled trial of treatment for alcohol problems: secondary analysis of the UK alcohol treatment trial (UKATT). Dale V., Coulton S., Godfrey C., Copello A., Hodgson R., Heather N., et al., p. 592-599.
• Heavy episodic drinking in europe: a cross section study in primary care in six European countries. Nazareth I., Walker C., Ridolfi A., Aluoja A., Bellon J., Geerlings M., et al., p. 600-606.
• Subjective measures of binge drinking, suboptimal subjective health and alcohol-specific hospitalizations among working-aged adults: a prospective cohort study. Paljarvi T., Suominen S., Car J., Makela P., Koskenvuo M., p. 607-613.
• Recent heavy alcohol consumption at death certified as ischaemic heart disease: correcting mortality data from kaunas (lithuania). Radisauskas R., Prochorskas R., Grabauskas V., Bernotiene G., Tamosiunas A., Veryga A., p. 614-619.
• Investigating ethnic differences in adolescent alcohol use and peer norms using semi-continuous latent growth models. Weaver S.R., Cheong J., Mackinnon D.P., Pentz M.A., p. 620-626.
• Alcoholic and non-alcoholic fatty liver in adolescents: a worrisome convergence. Nobili V., Pinzani M., p. 627-629.
• Exposure to alcohol advertising and alcohol consumption among Australian adolescents. Jones S.C., Magee C.A., p. 630-637.
• Hazardous drinking concepts, limits and methods: low levels of awareness, knowledge and use in the Swedish population. Bendtsen P., Karlsson N., Dalal K., Nilsen P., p. 638-645.